VTAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the data provided, Catheter Precision Inc (VTAK) does not appear to be a strong buy for a beginner investor with a long-term focus. The lack of positive trading signals, weak financial performance, and absence of news or catalysts suggest that holding off on investing in this stock is prudent at this time.
The MACD is above 0 but positively contracting, indicating a weakening bullish momentum. RSI is neutral at 31.614, and moving averages are converging, suggesting no clear trend. The pre-market price is down 5.92%, and the stock is trading near its support level of 0.846, which could indicate potential downside risk.
Revenue increased by 59.73% YoY in Q4 2025, indicating some growth potential.
Net income dropped significantly (-46.43% YoY), EPS fell drastically (-84.21% YoY), and gross margin declined slightly (-1.10% YoY). No significant trading trends from hedge funds or insiders, and no recent news or catalysts to drive the stock upward.
In Q4 2025, revenue grew by 59.73% YoY to $238,000, but net income dropped to -$5,778,000 (-46.43% YoY). EPS declined sharply to -3.41 (-84.21% YoY), and gross margin fell slightly to 91.6% (-1.10% YoY). Overall, the financial performance indicates weak profitability and high losses.
No analyst rating or price target changes available for evaluation.
